Madagascar should introduce typhoid conjugate vaccines now

Lancet. 2018 Oct 13;392(10155):1309-1310. doi: 10.1016/S0140-6736(18)31882-8.

Authors

Florian Marks¹, Jerome H Kim², Raphaël Rakotozandrindrainy³

Affiliations

¹ International Vaccine Institute, Seoul 08826, South Korea; The Department of Medicine, University of Cambridge, Cambridge, UK. Electronic address: fmarks@ivi.int.
² International Vaccine Institute, Seoul 08826, South Korea.
³ Laboratoire de Microbiologie et de Parasitologie, University of Antananarivo, Antananarivo, Madagascar.

PMID: 30322578
DOI: 10.1016/S0140-6736(18)31882-8

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Madagascar / epidemiology
Typhoid Fever / epidemiology
Typhoid Fever / immunology
Typhoid Fever / prevention & control*
Typhoid-Paratyphoid Vaccines / administration & dosage
Typhoid-Paratyphoid Vaccines / immunology*
Vaccines, Conjugate / administration & dosage
Vaccines, Conjugate / immunology

Substances

Typhoid-Paratyphoid Vaccines
Vaccines, Conjugate